Erdogan-Trinkaus Ipek
SEC insider (Form 3/4/5 filer). CIK 0002047026. Chief Commercial Officer at Eton Pharmaceuticals, Inc. (ETON). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in DEERPARK, IL.
Companies Erdogan-Trinkaus Ipek has filed insider reports for
- Eton Pharmaceuticals, Inc. (ETON): Officer, Chief Commercial Officer
Erdogan-Trinkaus Ipek
CIK: 0002047026
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eton Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 31, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectCommon Stock
80K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
40.7K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
25.9K shares- - Dec 12, 2025ETON
Eton Pharmaceuticals, Inc.
Tax PaymentDirect85 shares at avg. $16.90$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Common Stock | 80,000 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Employee Stock Option (Right to Buy) | 40,655 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Restricted Stock Units | 25,856 | - | - | Direct |
| Dec 12, 2025 | ETON Eton Pharmaceuticals, Inc. | Tax Payment | 85 | $16.90 | $1,436 | Direct |
1-4 of 4 transactions